Clincosm LogoSign in Get a demo

HIV Infections

Showing NaN - NaN of 609
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

People Living With HIV, Oral and Oropharyngeal Cancer, and

Not yet recruiting
  • HIV Infections
  • +2 more
  • Group Meeting (Focus Group)
  • Questionnaires
  • San Francisco, California
    University of California, San Francisco
Sep 20, 2023

Heart Failure With Reduced Ejection Fraction, HIV Trial in San Francisco (Heart failure polypill, Control Rx)

Not yet recruiting
  • Heart Failure With Reduced Ejection Fraction
  • HIV Infections
  • Heart failure polypill
  • Control Rx
  • San Francisco, California
    Zuckerberg San Francisco General Hospital
Sep 1, 2023

HIV Trial in Puerto Rico, United States (VH3810109, Cabotegravir, Standard of care (SOC))

Not yet recruiting
  • HIV Infections
  • VH3810109
  • +3 more
  • Birmingham, Alabama
  • +42 more
Aug 9, 2023

HIV Trial in San Francisco (Patient-centered injection site, Patient-centered adherence support, Provider education)

Recruiting
  • HIV Infections
  • Patient-centered injection site
  • +3 more
  • San Francisco, California
    Bridge HIV, San Francisco Department of Public Health
Jul 31, 2023

HIV Trial in South Africa, United States (sD-NP-GT8 DNA, IL-12 DNA, Trimer 4571)

Not yet recruiting
  • HIV Infections
  • sD-NP-GT8 DNA
  • +4 more
  • Birmingham, Alabama
  • +5 more
Mar 10, 2023

HIV Trial in Philadelphia (3BNC117-LS, 10-1074-LS)

Suspended
  • HIV Infections
  • Birmingham, Alabama
  • +5 more
Jan 31, 2023

Hepatitis B, HIV Trial in Worldwide (Selgantolimod, Placebo)

Recruiting
  • Hepatitis B
  • HIV Infections
  • San Diego, California
  • +35 more
Jan 31, 2023

HIV Trial in Worldwide (Cabotegravir Tablets, Cabotegravir Injectable Suspension (CAB LA), Rilpivirine Tablets)

Active, not recruiting
  • HIV Infections
  • Cabotegravir Tablets
  • +4 more
  • Bakersfield, California
  • +116 more
Jan 22, 2023

Consent for Use of Stored Patient Specimens for Future Testing

Recruiting
  • HIV Infections
    • Los Angeles, California
    • +62 more
    Dec 7, 2022

    HIV Trial in United States (APRETUDE, Cabotegravir OLI)

    Recruiting
    • HIV Infections
    • Los Angeles, California
    • +16 more
    Oct 24, 2022

    Lipodystrophy, HIV Trial in Worldwide (Tesamorelin, Placebo for Tesamorelin)

    Completed
    Has Results
    • Lipodystrophy
    • HIV Infections
    • Birmingham, Alabama
    • +46 more
    Sep 16, 2022

    HIV, Sexually Transmitted Diseases Trial in San Francisco, Washington, Miami (PrEPmate, Dot Diary)

    Recruiting
    • HIV Infections
    • Sexually Transmitted Diseases
    • PrEPmate
    • Dot Diary
    • San Francisco, California
    • +3 more
    Sep 27, 2022

    HIV Trial in Worldwide (PGDM1400LS (5mg/kg, IV), PGDM1400LS (20mg/kg, IV), PGDM1400LS (20mg/kg, SC))

    Recruiting
    • HIV Infections
    • PGDM1400LS (5mg/kg, IV)
    • +16 more
    • San Francisco, California
    • +13 more
    Aug 12, 2022

    Dyslipidemias, Cardiovascular Diseases, HIV Trial in San Francisco (Bempedoic acid, Placebo)

    Not yet recruiting
    • Dyslipidemias
    • +3 more
    • Bempedoic acid
    • Placebo
    • San Francisco, California
      San Francisco General Hospital
    Aug 3, 2022

    Antiretroviral Drugs and Related Drugs During and After

    Completed
    Has Results
    • HIV Infections
    • Birmingham, Alabama
    • +61 more
    Jun 28, 2022

    Cytomegalovirus Infections, HIV, Vaccine Trial in United States (CMV-MVA Triplex, Placebo)

    Recruiting
    • Cytomegalovirus Infections
    • +2 more
    • CMV-MVA Triplex
    • Placebo
    • Birmingham, Alabama
    • +11 more
    Jun 20, 2022

    HIV, Cytomegalovirus, CMV Trial in United States (Letermovir 240 MG Oral Tablet, Letermovir 480 MG Oral Tablet, Combination ART)

    Recruiting
    • HIV Infections
    • +2 more
    • Letermovir 240 MG Oral Tablet
    • +2 more
    • Birmingham, Alabama
    • +18 more
    Jun 20, 2022

    HIV Trial in Sacramento, San Francisco (drug, biological, other)

    Recruiting
    • HIV Infections
    • Sacramento, California
    • +1 more
    May 17, 2022

    HIV Trial in Birmingham, San Francisco, Pittsburgh (Tenofovir (TFV) IVR, Placebo IVR)

    Completed
    • HIV Infections
    • Tenofovir (TFV) IVR
    • Placebo IVR
    • Birmingham, Alabama
    • +2 more
    May 2, 2022

    HIV, HIV Primary Infection Trial in San Francisco (CHIP, Control)

    Recruiting
    • HIV Infections
    • HIV Primary Infection
    • CHIP
    • Control
    • San Francisco, California
      University of California, San Francisco
    Feb 28, 2022

    HIV Trial in United States (Doravirine 100 Mg, Tenofovir alafenamide/emtricitabine, tenofovir alafenamide/lamivudine)

    Recruiting
    • HIV Infections
    • Doravirine 100 Mg
    • +5 more
    • Birmingham, Alabama
    • +22 more
    Feb 22, 2022

    HIV Trial in Worldwide (VRC01, Placebo for VRC01)

    Completed
    Has Results
    • HIV Infections
    • VRC01
    • Placebo for VRC01
    • Birmingham, Alabama
    • +25 more
    Feb 8, 2022

    HIV, Stigma, Social Trial in San Francisco (Standard of care engagement practices, Peer Navigators Addressing INtersectional

    Recruiting
    • HIV Infections
    • Stigma, Social
    • Standard of care engagement practices
    • Peer Navigators Addressing INtersectional Stigma to Improve HIV Prevention Among Criminal-Justice Involved Women
    • San Francisco, California
      University of California San Francisco
    Feb 1, 2022

    HIV Trial in Puerto Rico, United States (Tamoxifen, Vorinostat, Antiretroviral drugs)

    Active, not recruiting
    Has Results
    • HIV Infections
    • Birmingham, Alabama
    • +13 more
    Jan 13, 2022

    HIV Trial in Worldwide (DTG 50 mg, RPV 25 mg, CAR)

    Active, not recruiting
    Has Results
    • HIV Infections
    • DTG 50 mg
    • +2 more
    • Long Beach, California
    • +64 more
    Dec 3, 2021